BP, valid point.
They are selling HIV test unit @ $20/unit B2C. B2B will be a lower unit price.
Though they plan to increase production to 10m by end of 2020, I expect sales volume to be less than this.
If they break even in the current FY will be really good.
Quarterly will be important to see.
Potential SP Valuation of AT1 - 80 cents to 1.30/share, page-4
-
- There are more pages in this discussion • 1,385 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
